Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$8.632M
Current Assets
2023 Q4
Current Liabilities
2023 Q4
Current Ratio
2023 Q4
241.41%
Total Assets
2023 Q4
Total Liabilities
2023 Q4
Book Value
2023 Q4
3.360M
Cash
2023 Q4
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$2.301M

Stock Price

Loading...
Market Cap: $2.498 Thousand

About Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Englewood, Colorado and currently employs 6 full-time employees. The company went IPO on 2011-05-19. The firm is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Industry: Pharmaceutical Preparations Peers: TREX WIND-DOWN, INC. cbdMD Inc PLx Pharma Winddown Corp. Eloxx Pharmaceuticals Inc Evofem Biosciences Inc Johnson & Johnson Vyne Therapeutics Inc OTONOMY, INC. Unrivaled Brands, Inc. TITAN PHARMACEUTICALS INC

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support